Chade AR - Search Results

1

Novel Drug Delivery Technologies and Targets for Renal Disease.

Chade AR, Bidwell GL 3rd. Chade AR, et al. Hypertension. 2022 Sep;79(9):1937-1948. doi: 10.1161/HYPERTENSIONAHA.122.17944. Epub 2022 Jun 2. Hypertension. 2022. PMID: 35652363 Free PMC article. Review.

2

Renal Therapeutic Angiogenesis Using a Bioengineered Polymer-Stabilized Vascular Endothelial Growth Factor Construct.

Chade AR, Tullos NA, Harvey TW, Mahdi F, Bidwell GL 3rd. Chade AR, et al. J Am Soc Nephrol. 2016 Jun;27(6):1741-52. doi: 10.1681/ASN.2015040346. Epub 2015 Nov 5. J Am Soc Nephrol. 2016. PMID: 26541349 Free PMC article.

3

A kidney-selective biopolymer for targeted drug delivery.

Bidwell GL 3rd, Mahdi F, Shao Q, Logue OC, Waller JP, Reese C, Chade AR. Bidwell GL 3rd, et al. Among authors: chade ar. Am J Physiol Renal Physiol. 2017 Jan 1;312(1):F54-F64. doi: 10.1152/ajprenal.00143.2016. Epub 2016 Oct 26. Am J Physiol Renal Physiol. 2017. PMID: 27784692 Free PMC article.

4

Small Vessels, Big Role: Renal Microcirculation and Progression of Renal Injury.

Chade AR. Chade AR. Hypertension. 2017 Apr;69(4):551-563. doi: 10.1161/HYPERTENSIONAHA.116.08319. Epub 2017 Feb 13. Hypertension. 2017. PMID: 28193706 Free PMC article. Review. No abstract available.

5

Systemic biopolymer-delivered vascular endothelial growth factor promotes therapeutic angiogenesis in experimental renovascular disease.

Chade AR, Williams ML, Guise E, Vincent LJ, Harvey TW, Kuna M, Mahdi F, Bidwell GL 3rd. Chade AR, et al. Kidney Int. 2018 Apr;93(4):842-854. doi: 10.1016/j.kint.2017.09.029. Epub 2017 Dec 19. Kidney Int. 2018. PMID: 29273331 Free PMC article.

6

Molecular Size Modulates Pharmacokinetics, Biodistribution, and Renal Deposition of the Drug Delivery Biopolymer Elastin-like Polypeptide.

Kuna M, Mahdi F, Chade AR, Bidwell GL 3rd. Kuna M, et al. Among authors: chade ar. Sci Rep. 2018 May 21;8(1):7923. doi: 10.1038/s41598-018-24897-9. Sci Rep. 2018. PMID: 29784932 Free PMC article.

7

Biopolymer-delivered vascular endothelial growth factor improves renal outcomes following revascularization.

Guise E, Engel JE, Williams ML, Mahdi F, Bidwell GL 3rd, Chade AR. Guise E, et al. Among authors: chade ar. Am J Physiol Renal Physiol. 2019 May 1;316(5):F1016-F1025. doi: 10.1152/ajprenal.00607.2018. Epub 2019 Mar 20. Am J Physiol Renal Physiol. 2019. PMID: 30892933 Free PMC article.

8

Targeted VEGF (Vascular Endothelial Growth Factor) Therapy Induces Long-Term Renal Recovery in Chronic Kidney Disease via Macrophage Polarization.

Engel JE, Williams E, Williams ML, Bidwell GL 3rd, Chade AR. Engel JE, et al. Among authors: chade ar. Hypertension. 2019 Nov;74(5):1113-1123. doi: 10.1161/HYPERTENSIONAHA.119.13469. Epub 2019 Sep 23. Hypertension. 2019. PMID: 31542966 Free PMC article.

9

Utilizing a Kidney-Targeting Peptide to Improve Renal Deposition of a Pro-Angiogenic Protein Biopolymer.

Mahdi F, Chade AR, Bidwell GL 3rd. Mahdi F, et al. Among authors: chade ar. Pharmaceutics. 2019 Oct 18;11(10):542. doi: 10.3390/pharmaceutics11100542. Pharmaceutics. 2019. PMID: 31635263 Free PMC article.

10

A Boolean Model of Microvascular Rarefaction to Predict Treatment Outcomes in Renal Disease.

Williams E, Chade AR. Williams E, et al. Among authors: chade ar. Sci Rep. 2020 Jan 16;10(1):440. doi: 10.1038/s41598-019-57386-8. Sci Rep. 2020. PMID: 31949240 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

111 results

Search Page

Filters